ATTGENO AB
556692-7751ActiveDeveloping targeted nitric oxide delivery drugs for critical care applications.
Biotechnology Companyattgeno.com
Översikt
- 1–4
- Anställda
- ≤1t SEK
- Omsättning
- 2005
- Grundat
Beskrivning
Attgeno is a Swedish biotechnology company focused on saving patient lives through advanced drug delivery systems. Their core mission revolves around the targeted delivery of nitric oxide (NO), a vital molecule in various physiological processes. The company is pioneering the third generation of NO...
Taggar
B2BPharmaceuticalsTechnology
Nyckelord
Biotechnology